2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. - Wikidata - awgldk - TriplyDB

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

http://www.wikidata.org/entity/Q54363395

about

Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future Preparing for an era of untreatable gonorrhea Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015)Gonorrhea - an evolving disease of the new millennium.Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae.Travel-associated gonorrhoea in four Nordic countries, 2008 to 2013 Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012.Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.Gonorrhea: Treatment update for an increasingly resistant organism Assessment of coinfection of sexually transmitted pathogen microbes by use of the anyplex II STI-7 molecular kit.Comparison of antimicrobial susceptibilities of pharyngeal, rectal, and urethral Neisseria gonorrhoeae isolates among men who have sex with men.Rapid change in the ciprofloxacin resistance pattern among Neisseria gonorrhoeae strains in Nuuk, Greenland: time to reconsider preventive and treatment strategies Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture.Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification and clustering of Neisseria gonorrhoeae.Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan.Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeae.Identification of Neisseria gonorrhoeae by the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System Is Improved by a Database Extension Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track?High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.Future treatment of gonorrhea--novel emerging drugs are essential and in progress?Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae.Recorded gonorrhoea rates in Denmark, 1900-2010: the impact of clinical testing activity and laboratory diagnostic procedures.Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.

P2860

Q26745785-07E5436B-8C10-44CE-A820-5F57854A735E Q26796265-0C23ACFB-C724-4E7F-B4DD-D7A32F95579C Q26862597-49744439-06BB-43CE-82DB-7BAD0FFE347E Q27002771-228F458E-676A-4716-BD70-41283023378B Q28552207-FCACDB1C-58B8-40E7-BA29-2673A6E05F14 Q28598089-14BFD6D7-55A1-4B4E-BECE-70854A4679D9 Q30235031-4DDC13FF-95B3-4888-B513-B519ACC617FB Q32383726-68A20381-A3AF-4BCC-90C9-CB03BBEA5252 Q33553128-B4A7B022-065E-4A4F-AB22-EFD9B5F1FFD3 Q33582278-469DD7B7-B8FC-48A9-8E3C-9D8D4642A4B5 Q33730287-10D280A8-71D8-4C59-9B8B-BA9D62B8E0D4 Q33797845-A2FDD31D-2474-44FA-BF2E-CD58595D39C9 Q33822880-6F6C6AF7-D3CC-4122-9C69-F9B267FB5106 Q33822930-E18C3D99-B2AE-4DDD-8D9F-4D9EE1CF80BB Q34057315-618618F6-8F78-449C-9E67-67DBA70554F0 Q34136098-E7FE3ABF-C2EB-430A-B288-DA727CBA16F1 Q34298905-E1BB614D-CE19-4B6D-BC8E-3CC5EC912CE0 Q34563908-7F8648F3-DD29-48D0-94A7-AE5E7753C13F Q34677116-542A8872-2F4A-40A7-A4E7-789C477CFF5D Q35076855-C111A1F2-3968-4400-8D33-A7F3B98BB472 Q35087427-9AEB8E83-3727-4007-8335-5A36E6958F41 Q35196687-E6914C7E-82BC-4493-AD5B-442436AC01E4 Q35331303-A53D6561-DD77-4BAD-A43B-0B5EF2384F0A Q35385910-3813E78B-220A-457E-9F03-67E17D01E4EB Q35578039-6FAC40A7-4F04-44B6-9DFF-7A2AEE249EEA Q35607393-925F7C0D-7672-425E-B61A-FAA7CADD16CB Q35708953-96A505B1-CAA9-45EE-BF8E-805ECD2A909A Q35741667-62B72596-85B1-45D6-B9EE-6E8F74311980 Q35779516-0C3F03D5-93CC-4DC2-A22B-8BDEEE9579CF Q35860111-0F7738F1-C617-4878-A5FE-31C63427633A Q35893443-B1DE2E2F-A35F-43DE-A66E-9412F4B6B05B Q35904738-16B043C9-81E6-4C53-B2BB-E3093CC812DE Q35961007-CA459A85-AE8D-420A-A7F0-1C7644F80E79 Q35962785-C8376D63-7647-4BF3-BA15-EE6438C62D7C Q35990421-5702B77F-FA37-445C-B72C-5AEC600120E4 Q35998223-E26D52B0-3C81-4F6E-BB2C-96F05D9EA5D0 Q36137744-3B6A3C9C-A08D-4136-8A6D-D48118526B8F Q36297569-05B5A677-9304-44C6-8781-41658AE8B88A Q36373896-CBA3053E-B31D-448B-A95C-95EFFEF8A110 Q36684164-48ED71E5-789C-47B7-9AD1-761BBF37C644

P2860

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

http://www.wikidata.org/entity/Q54363395

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

@en

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

@nl

type

label

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

@en

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

@nl

prefLabel

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

@en

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

@nl

P1433

Q54363395-9F5AFE23-247F-47E8-A437-553C6A1BA7C6

P1476

Q54363395-C55A029A-521A-4804-BE13-F55400B9324D

P2093

Q54363395-24CD482B-48A1-4194-AC3D-C646B4E3BFDB

Q54363395-A2450C42-C49F-40EF-AF09-058CE1D4D08C

Q54363395-AC59AE06-866D-4E0D-A98D-EF71E6F9959A

P2860

Q54363395-06D4B474-4356-41F8-8DD9-8C6C7EDA9F17

Q54363395-0A31C06F-74C7-4A5C-BBA8-5CA0B999BC11

Q54363395-1E409759-F6AF-4DC3-BDF7-D4D76C070573

Q54363395-20B4F74F-2409-4BBF-892A-F71522C2A440

Q54363395-238B7F1A-EE62-4F3F-8BAC-A64275E11A6B

Q54363395-288CA5CB-ED16-4524-A52D-4D1AE4C2CC4B

Q54363395-2D443C25-5A44-4D8F-86C5-88458D9EF838

Q54363395-2D8AEB44-A4E4-4F98-8668-C5C0312C41D6

Q54363395-300F1528-C04E-4BE3-9DC8-8B5E0FE9A70D

Q54363395-33462D86-7EE0-4DBA-849F-80DA1E3AC363

P304

Q54363395-0EDE40B8-EA09-4E1F-B55B-C575F8AEBDA5

P31

Q54363395-C190055E-701E-435C-B5B7-F3D3CEC478A2

P356

Q54363395-A66B0C8A-3CC3-4C1C-814E-0829CD112D82

P433

Q54363395-1B3A0282-40A3-4A1F-99A0-1CF8F8A525A0

P478

Q54363395-92F54DD3-49D2-4322-9DCA-7D523C6BD6DE

P577

Q54363395-2CD0DD3B-CF8D-4B73-B9D6-3D41CB332EDC

P698

Q54363395-7D3A1402-6C6A-4A34-8893-F9F32C18F9B2

P356

0956462412472837

P1433

International Journal of STD & AIDS

P1476

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

@en

P2093

C Bignell

http://www.w3.org/2001/XMLSchema#string

European STI Guidelines Editorial Board

http://www.w3.org/2001/XMLSchema#string

M Unemo

http://www.w3.org/2001/XMLSchema#string

P2860

Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.

A one-year survey of gonococcal infection seen in the genitourinary medicine department of a London district general hospital.

Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.

Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.

Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests.

High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes

Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea

Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.

Drugs of choice for the treatment of uncomplicated gonococcal infections.

Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae.

P304

85-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0956462412472837

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24400344

http://www.w3.org/2001/XMLSchema#string